ODDB.org: Open Drug Database

Swissmedic Registration	65041	Date of registration	12.09.2014
Company name	Novo Nordisk Pharma AG	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	07.06.10.	Revocation Date
Index Therapeuticus (Swissmedic)	07.06.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml	Injektionslösung	Injection solution ( 600 , 0 , 3.6 mg/ml)	A10AE56	CI

2025	©ywesee GmbH